Inactive Instrument
Canntab Therapeutics Limited Share Price
Stocks
CTABF
CA1377991023
Pharmaceuticals
OTC Markets Traded| 1 day | -99.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 15/05/2020 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 01/09/2018 |
Eric Malinski
SAM | Sales & Marketing | - | 01/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/02/24 | Option | Director | 1,00,000 | 0.2570% | ||
| 06/02/24 | Option | Director | 1,00,000 | 0.2570% | ||
| 22/02/22 | Sell | Chief Executive Officer | 4,00,000 | 1.0717% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.00% | -.--% | - | - | 38 | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,20000Cr | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 65TCr | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 51TCr | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 38TCr | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 33TCr | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 29TCr | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 27TCr | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 24TCr | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 21TCr | ||
| Average | -9.60% | -4.76% | +25.01% | +75.64% | 45TCr | |
| Weighted average by Cap. | +0.30% | -5.19% | +26.02% | +87.88% |
Employees
-
Sector
Pharmaceuticals
















